Abstract. Cyclooxygenase-2 (COX-2) serves an important role in the carcinogenesis and progression of gastric cancer. Harmine (HM) and paclitaxel (PTX) are reported as promising drug candidates for cancer therapy, but whether a synergistic anti-tumor effect of HM combined with PTX exists in human gastric cancer remains unknown. The present study evaluated the effects of HM and/or PTX on cell proliferation and apoptosis in a gastric cancer cell line, SGC-7901. HM and PTX inhibited cell proliferation in a dose-dependent manner. Both HM and PTX alone induced apoptosis in gastric cancer cells. The combination of HM and PTX exerted synergistic effects on proliferation inhibition and apoptosis induction in SGC-7901 cells, with down-regulation of COX-2, PCNA and Bcl-2 and up-regulation of Bax expression. The results indicated that combination chemotherapy using HM with PTX exerts an anti-tumor effect for treating gastric cancer. The combination of the two drugs inhibits gastric cancer development more effectively than each drug alone through down-regulation of COX-2 expression.
IntroductionGastric cancer has been a significant health problem worldwide due to its poor prognosis and increasing incidence (1). According to the latest literature, 800,000 cancer-associated mortalities are caused by gastric cancer each year globally, making it the second leading cause of cancer-associated mortalities in the world (2,3). At present, chemotherapy has become one of the major means for treating gastric cancer of middle and advanced stages (4,5). As a standard anticancer drug, paclitaxel (PTX) serves a significant role in the treatment of a number of tumors. As reported in latest studies, the efficiency of single anticancer drug-paclitaxel reaches 11-23% in treating the gastric cancer of middle and advanced stages, while that of drug combination therapy is 50-60% (6). Harmine (HM), originally isolated from the seeds of Peganum harmala, is a tricyclic compound belonging to the β-carboline alkaloids. It inhibits the proliferation of tumor cells and induces apoptosis, and it performs well in reducing angiogenesis, tumor promotion and mutation (7,8). It has become a new focus in the chemoprevention study about cancer in recent years. Recent studies have demonstrated that HM possessed significant anti-tumor potential both in vitro and in vivo (9,10). However, the synergistic anti-tumor effect of a combination of HM and PTX on human gastric cancer remains unknown.Cyclooxygenase (COX), a key enzyme in the conversion of arachidonic acid to prostaglandins (PGs) and other eicosanoids, exists as two isoforms: Constitutive COX-1 and mitogen-inducible COX-2. COX-2 is also constitutively expressed in gastric cancer and is related to cell proliferation and apoptosis, tumor invasiveness and metastasis (11). Our previous studies have demonstrated that COX-2 inhibition by selective COX-2 inhibitors or small interfering RNA (siRNA) could suppress cell proliferation and induces apoptosis in human gastric cancer cells (12,13). Recently, we demonstrated...